ClinicalTrials.gg
RecruitingNCT07948707remote monitorUpdated Nov 19, 2026

Effect of Nurse-Led Remote Monitoring and Patient Navigation on Psychological Distress and Self-Management

An interventional study of Nurse-Led Remote Monitoring and Patient Navigation in Psychological Distress and Self-Management, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Cairo University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Diabetes mellitus is a chronic condition that often imposes significant psychological distress and requires complex daily self-management. This randomized controlled trial aims to evaluate the effectiveness of a structured nurse-led intervention combined with patient navigation on reducing psychological distress and improving self-management behaviors among patients with diabetes. Eligible adult patients with diabetes will be randomly assigned into either an intervention group receiving the nurse-led educational, psychosocial, and navigation support program alongside routine care, or a control group receiving routine diabetes care alone. Outcomes related to diabetes-related psychological distress and self-care adherence will be assessed at baseline and following the intervention period to determine the clinical impact of the program.

Read the detailed description

Background and Rationale:

Living with diabetes requires continuous lifestyle modifications, medication adherence, and blood glucose monitoring, which frequently lead to diabetes-related psychological distress, anxiety, and burnout. High levels of psychological distress negatively affect treatment adherence and glycemic control. Nurse-led interventions coupled with patient navigation offer a holistic, patient-centered approach by providing tailored health education, emotional support, problem-solving skills, and assistance in overcoming healthcare system barriers.

Study Objective:

The primary objective of this study is to examine the effect of a nurse-led intervention and patient navigation program on psychological distress and diabetes self-management among patients with diabetes.

Study Design and Methodology:

This study utilizes a two-arm, parallel-group randomized controlled trial (RCT) design. After obtaining informed consent and completing baseline assessments, eligible participants will be randomly allocated in a 1:1 ratio into two equal groups:

  1. Intervention Group: Participants will receive a structured nurse-led intervention and patient navigation program in addition to standard care. The intervention encompasses individualized diabetes self-management education, psychological and coping support, goal setting, care coordination, and regular follow-up reminders to facilitate access to healthcare services and address barriers to care.
  2. Control Group: Participants will continue to receive their standard routine diabetes care without the additional navigation or nurse-led sessions.

Outcome Assessment:

Both groups will be evaluated at baseline (pre-test) and after completion of the intervention (post-test) using validated psychometric and behavioral instruments measuring diabetes-related psychological distress (such as the Diabetes Distress Scale) and diabetes self-management practices (such as the Summary of Diabetes Self-Care Activities). Data will be statistically analyzed to compare pre- and post-intervention changes within and between the two study groups.

02

Conditions studied

  • Psychological Distress and Self-Management

Keywords

  • Nurse led
  • Remote monitoring
  • Patient navigation
  • Psychological distress
  • Self management
  • Diabetes patients
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,965 studies on the registry; 1,474 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Participants will be included in the study if they meet the following criteria:

  1. Adults aged 18 years or older.
  2. Patients with a confirmed diagnosis of type 1 or type 2 diabetes mellitus.
  3. Patients receiving routine diabetes care at the selected study setting.
  4. Patients who have access to a telephone or another suitable remote communication method.
  5. Patients who are willing to participate in the study and provide written .
  6. Patients who are able to understand and complete the study questionnaires in the selected validated language.
  7. Patients who are expected to be available throughout the intervention and follow-up period

Exclusion criteria

Exclusion Criteria:

  1. Patients experiencing an acute medical condition requiring emergency treatment or hospitalization at the time of recruitment.
  2. Patients with severe cognitive impairment or communication difficulties that prevent meaningful participation in the intervention and completion of the assessment tools.
  3. Patients experiencing an acute psychiatric crisis requiring immediate specialized mental health intervention.
  4. Patients enrolled in another intensive remote diabetes-management program that could substantially overlap with the proposed intervention.
  5. Patients who decline participation or withdraw their . Note: A previous diagnosis of depression or anxiety should not automatically be an exclusion criterion unless justified by the study protocol. Including patients with stable mental health conditions may improve the applicability of the findings concerning psychological distress among diabetic patients.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Nurse led intervention and patient navigation

    Participants will receive a nurse-led remote monitoring and patient navigation intervention aimed at supporting their psychological well-being and managing psychological distress over the intervention period.

    Other: Nurse-Led Remote Monitoring and Patient Navigation

  • No intervention
    Usual care group

    Participants will receive usual care without the nurse-led remote monitoring and patient navigation intervention.

Interventions

  • OtherNurse-Led Remote Monitoring and Patient Navigation

    Nurse-led remote monitoring and patient navigation: refers to a structured, eight-week intervention delivered by a trained community health nurse through scheduled telephone calls or other agreed remote communication methods. It includes reviewing patients' reported health status, reinforcing diabetes self-management education, identifying barriers to healthcare access, facilitating appointments and referrals, and coordinating follow-up with healthcare providers.

06

What researchers measure

Primary outcomes

  1. changes in psychological distress

    Assessment of changes in psychological distress among participants using the specified psychological distress assessment scale, comparing baseline and post-intervention measurements.

    Time frame: 3 months

  2. Change in Diabetes Self-Management

    Assessment of changes in diabetes self-management among participants using the specified diabetes self-management assessment tool, comparing baseline and post-intervention measurements.

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
  • The study will be conducted at the Diabetes and Endocrinology Outpatient Clinics of Helwan General Hospital, a major secondary-level governmental healthcare facility operating under the Ministry of Health and Population in Cairo, Egypt.
    Cairo, Egypt
    Recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Individual participant data (IPD) collected during this study will not be shared with other researchers. The data will be used exclusively for the purposes of the current study and will be kept confidential to protect participants' privacy.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2026 to primary completion in Oct 2026, 0 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2026
First posted
Nov 19, 2026
StartActual
Oct 12, 2026
Primary completionActual
Oct 12, 2026
CompletionEst.
Jan 1, 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07948707
Lead sponsor
Cairo University
Responsible party
doaa mansour ali (assisstant professor, Cairo University) — Principal investigator
First posted
Nov 19, 2026
Start date
Oct 12, 2026
Primary completion
Oct 12, 2026
Completion
Jan 1, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Doaa mansour Ali, assisstant professor
Contact
dodo8836@yahoo.com
01116240970
Doaa MANSOUR Ali, ASSISSTANT PROFESSOR
principal investigator · Cairo University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion